Top 7 China Smart Healthcare & Medical AI Companies 2025
China's smart healthcare market exceeded RMB 120 billion in 2025, driven by NMPA-approved AI diagnostic devices, AI-assisted drug discovery, and large-scale intelligent hospital deployments. Over 300 AI medical devices have received NMPA approval, with applications spanning radiology, pathology, ophthalmology, and cardiovascular diagnostics across 2,000+ hospitals nationwide.
TL;DR: China's smart healthcare market exceeds RMB 120B. UnitedImaging leads with AI-powered imaging deployed in 1,500+ hospitals, while SenseTime Medical offers 50+ NMPA-approved AI diagnostic tools. The sector has 300+ NMPA-approved AI medical devices.
Top Companies
UnitedImaging (联影智能)
1,500+ hospitalsUnitedImaging provides AI-powered medical imaging systems including CT, MRI, and PET/CT with integrated AI diagnostic capabilities. Its uAI platform offers 40+ AI applications for automatic image analysis, deployed in 1,500+ hospitals across China and 60+ countries.
SenseTime Medical (商汤医疗)
50+ NMPA approvalsSenseTime Medical is the AI medical division of SenseTime Group, offering 50+ NMPA-approved AI diagnostic tools. Its SenseCare platform provides AI-assisted diagnosis for chest X-rays, CT scans, pathology slides, and retinal imaging, serving 300+ hospitals.
iFlytek Healthcare (科大讯飞医疗)
300+ hospitalsiFlytek provides AI-powered clinical decision support systems and intelligent medical record solutions. Its AI doctor assistant system passes medical licensing exams with expert-level accuracy and is deployed in 300+ hospitals for diagnostic assistance and clinical documentation.
Infervision (推想医疗)
40+ NMPA approvalsInfervision specializes in AI-powered medical imaging diagnosis, with 40+ NMPA-approved products for lung nodule detection, stroke assessment, and COVID-19 screening. Its InferRead platform processes 100M+ medical images annually across 500+ hospitals in 20+ countries.
Yidu Cloud (医渡云)
800+ hospitalsYidu Cloud provides AI-powered hospital intelligence and big data platforms for clinical research and precision medicine. Its platform processes medical records from 800+ hospitals, supporting disease prediction, drug safety surveillance, and clinical trial matching.
Deepwise (深睿医疗)
30+ AI productsDeepwise develops AI medical imaging solutions for multi-organ analysis including lung, brain, heart, and bone. Its Dr.Wise platform provides 30+ AI products deployed in 400+ hospitals, covering radiology, pathology, and ultrasound diagnostics.
Tencent Miying (腾讯觅影)
100+ hospitalsTencent Miying is Tencent's AI medical imaging platform, offering AI diagnostics for endoscopy, lung cancer screening, diabetic retinopathy, and cardiovascular disease. It serves 100+ hospitals and provides free AI screening services in underserved regions through its public health initiatives.
Comparison Table
| Company | AI Focus | NMPA Approvals | Hospital Coverage | Key Product |
|---|---|---|---|---|
| UnitedImaging | Medical imaging | 40+ | 1,500+ | uAI platform |
| SenseTime Medical | Multi-organ diagnosis | 50+ | 300+ | SenseCare platform |
| iFlytek Healthcare | Clinical decision support | 20+ | 300+ | AI Doctor Assistant |
| Infervision | Lung/stroke imaging | 40+ | 500+ | InferRead platform |
| Yidu Cloud | Hospital intelligence | 15+ | 800+ | YiduCore platform |
| Deepwise | Multi-organ imaging | 30+ | 400+ | Dr.Wise platform |
| Tencent Miying | Endoscopy + screening | 10+ | 100+ | Miying AI platform |
Frequently Asked Questions
How many AI medical devices are approved in China?
As of 2025, over 300 AI medical devices have received NMPA (National Medical Products Administration) approval in China. The majority are AI-assisted diagnostic software for radiology, pathology, and ophthalmology, along with some AI-powered medical imaging hardware systems.
Can AI replace doctors in Chinese hospitals?
AI in Chinese hospitals serves as a decision support tool, not a replacement for doctors. AI systems flag potential abnormalities for radiologist review, improving diagnostic speed and reducing missed diagnoses. Final clinical decisions remain with licensed physicians.
How is AI used in Chinese drug discovery?
Chinese companies like XtalPi, Insilico Medicine, and ByteDance use AI for molecular optimization, target identification, and clinical trial design. XtalPi's AI platform can predict molecular properties 100x faster than traditional methods, reducing drug development timelines by 2-3 years.
What is China's smart hospital policy?
China's National Health Commission promotes 'smart hospitals' with three levels: smart medical services (AI diagnostics), smart services (online appointments, mobile payments), and smart management (IoT-enabled operations). Over 1,700 hospitals have achieved Level 3+ smart hospital certification.
Which Chinese company leads AI medical imaging?
UnitedImaging (联影智能) leads in hardware-integrated AI imaging, while SenseTime Medical (商汤医疗) has the most NMPA approvals. Infervision (推想医疗) specializes in lung and stroke imaging with the broadest international deployment among Chinese AI medical companies.